Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Huanle Gong

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Cellular & Molecular Immunology|August 5, 2014
The S1P1 receptor-selective agonist CYM-5442 reduces the severity of acute GVHD by inhibiting macrophage recruitmentQiao Cheng, Shoubao Ma, Dandan Lin, et al.
Cell Reports|February 27, 2024
IL-37 dampens immunosuppressive functions of MDSCs via metabolic reprogramming in the tumor microenvironmentYu Mei, Ying Zhu, Kylie Su Mei Yong, et al.
European Journal of Immunology|December 29, 2017
IL-12/IL-18-preactivated donor NK cells enhance GVL effects and mitigate GvHD after allogeneic hematopoietic stem cell transplantationYuan Song, Bo Hu, Yonghao Liu, et al.
Signal Transduction and Targeted Therapy|September 15, 2022
Dendritic cell-derived IL-27 p28 regulates T cell program in pathogenicity and alleviates acute graft-versus-host diseaseHuanle Gong, Shoubao Ma, Jia Chen, et al.
Experimental Hematology & Oncology|June 2, 2022
IL-39 promotes chronic graft-versus-host disease by increasing T and B Cell pathogenicityKangkang Lv, Bo Hu, Mingzhu Xu, et al.
Frontiers in Immunology|December 17, 2020
IL-Y Aggravates Murine Chronic Graft-<i>Versus</i>-Host Disease by Enhancing T and B Cell ResponsesLi Wan, Ziqi Jin, Bo Hu, et al.
Frontiers in Immunology|December 12, 2018
IL-17C Mitigates Murine Acute Graft-vs.-Host Disease by Promoting Intestinal Barrier Functions and Treg DifferentiationHuanle Gong, Shoubao Ma, Shuangzhu Liu, et al.
Leukemia|November 23, 2024
Dimethyl fumarate ameliorates chronic graft-versus-host disease by inhibiting Tfh differentiation via Nrf2Fulian Lyu, Huanle Gong, Xiaojin Wu, et al.
Ebiomedicine|March 5, 2019
NCR<sup>-</sup> group 3 innate lymphoid cells orchestrate IL-23/IL-17 axis to promote hepatocellular carcinoma developmentYonghao Liu, Yuan Song, Dandan Lin, et al.
Frontiers in Immunology|July 5, 2022
Fucosylation Promotes Cytolytic Function and Accumulation of NK Cells in B Cell LymphomaXing Tong, Yuhua Ru, Jianhong Fu, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Cellular & Molecular Immunology|August 5, 2014
The S1P1 receptor-selective agonist CYM-5442 reduces the severity of acute GVHD by inhibiting macrophage recruitmentQiao Cheng, Shoubao Ma, Dandan Lin, et al.
Cell Reports|February 27, 2024
IL-37 dampens immunosuppressive functions of MDSCs via metabolic reprogramming in the tumor microenvironmentYu Mei, Ying Zhu, Kylie Su Mei Yong, et al.
European Journal of Immunology|December 29, 2017
IL-12/IL-18-preactivated donor NK cells enhance GVL effects and mitigate GvHD after allogeneic hematopoietic stem cell transplantationYuan Song, Bo Hu, Yonghao Liu, et al.
Signal Transduction and Targeted Therapy|September 15, 2022
Dendritic cell-derived IL-27 p28 regulates T cell program in pathogenicity and alleviates acute graft-versus-host diseaseHuanle Gong, Shoubao Ma, Jia Chen, et al.
Experimental Hematology & Oncology|June 2, 2022
IL-39 promotes chronic graft-versus-host disease by increasing T and B Cell pathogenicityKangkang Lv, Bo Hu, Mingzhu Xu, et al.
Frontiers in Immunology|December 17, 2020
IL-Y Aggravates Murine Chronic Graft-<i>Versus</i>-Host Disease by Enhancing T and B Cell ResponsesLi Wan, Ziqi Jin, Bo Hu, et al.
Frontiers in Immunology|December 12, 2018
IL-17C Mitigates Murine Acute Graft-vs.-Host Disease by Promoting Intestinal Barrier Functions and Treg DifferentiationHuanle Gong, Shoubao Ma, Shuangzhu Liu, et al.
Leukemia|November 23, 2024
Dimethyl fumarate ameliorates chronic graft-versus-host disease by inhibiting Tfh differentiation via Nrf2Fulian Lyu, Huanle Gong, Xiaojin Wu, et al.
Ebiomedicine|March 5, 2019
NCR<sup>-</sup> group 3 innate lymphoid cells orchestrate IL-23/IL-17 axis to promote hepatocellular carcinoma developmentYonghao Liu, Yuan Song, Dandan Lin, et al.
Frontiers in Immunology|July 5, 2022
Fucosylation Promotes Cytolytic Function and Accumulation of NK Cells in B Cell LymphomaXing Tong, Yuhua Ru, Jianhong Fu, et al.
Pageof 3